Hydrogen sulfide and the vasculature: A novel vasculoprotective entity and regulator of nitric oxide bioavailability?

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 3, 2009, Pages 488-507

  Whiteman, Matthew ^a   Moore, Philip K ^b  

^a PENINSULA MEDICAL SCHOOL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cardioprotection; Gaseous mediators; KATP; Nitrosothiol; Reactive nitrogen species; Sulfur; Vasodilator

Indexed keywords

HYDROGEN SULFIDE; NITRIC OXIDE;

ANIMAL; BIOAVAILABILITY; BLOOD VESSEL; HUMAN; METABOLISM; PH; REVIEW;

ANIMALS; BIOLOGICAL AVAILABILITY; BLOOD VESSELS; HUMANS; HYDROGEN SULFIDE; HYDROGEN-ION CONCENTRATION; NITRIC OXIDE;

ANIMALIA;

EID: 63049105151     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2009.00645.x     Document Type: Review

References (124)

1. Integrated Risk Information System. (2003) Toxicological review of hydrogen sulphide. U.S. Environmental Protection Agency EPA/635/R-03/005 www. document URL http://www.epa.gov/ncea/iris/toxreviews/0061-tr.pdf accessed September 1 2008 CAS No. 7783-064.
2. Leigh GJ. Nomenclature of inorganic chemistry recommendations. IUPAC Chemical Data Series, 1990 pp. 1 3.
3. McNaught A. Spelling of sulfur. J. Mat. Chem. 1991 5 : 716 16.
4. Pacher P, Beckman JS, Liaudet L. (2007). Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007 87 : 315 424.
5. Greenacre SAB, Ischiropoulos H. Tyrosine nitration: localisation, quantification, consequences for protein function and signal transduction. Free Radic Res. 2001 34 : 541 81.
6. Halliwell B, Zhao K, Whiteman M. Nitric oxide and peroxynitrite. The ugly, the uglier and the not so good: a personal view of recent controversies. Free Radic Res. 1999 31 : 651 9.
7. Wimalawansa SJ. Nitric oxide: new evidence for novel therapeutic indications. Expert Opin Pharmacother. 2008 9 : 1935 54.
8. Seddon MD, Chowienczyk PJ, Brett SE, Casadei B, Shah AM. Neuronal nitric oxide synthase regulates basal microvas-cular tone in humans in vivo. Circulation. 2008 117 : 1991 6.
9. Giles TD. Aspects of nitric oxide in health and disease: a focus on hypertension and cardiovascular disease. Clin Hypertens. 2006 8 : 2 16.
10. Bath PM, Willmot M, Leonardi-Bee J, Bath FJ. Nitric oxide donors (nitrates), L-arginine, or nitric oxide synthase inhibitors for acute stroke. Cochrane Database Syst Rev. 2002 4 : DOI :.
11. Whiteman M, Armstrong JS, Chu SH, Siau J-L, Cheung NS, Halliwell B, Moore PK. The novel neuromodulator hydrogen sulphide: an endogenous peroxynitrite 'scavenger'? J Neurochem. 2004 90 : 765 8.
12. Mester A, Fraser PE, Tice SV. Enzymatic desulfuration of (β-mercaptopyruvate to pyruvate. J Biol Chem. 1954 206 : 516 75.
13. Dombkowski RA, Russel MJ, Olson KR. Hydrogen sulfide as an endogenous regulator of vascular smooth muscle tone in trout. Am J Physiol Regul Integr Comp Physiol. 2004 286 : R678 85.
14. Li L, Bhatia M, Zhu Y-Z, Zhu YC, Ramnath RD, Wang ZJ, Anuar FBM, Whiteman M, Salto-Tellez M, Moore PK. Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB J. 2005 19 : 1196 8.
15. Yusuf M. Huat BTKH, Hsu A, Whiteman M, Bhatia M, Moore PK. Streptozotocin-induced diabetes in the rat is associated with enhanced tissue hydrogen sulfide biosynthesis. Biochem Biophys Res Commun. 2005 333 : 1146 52.
16. Bhatia M, Wong FL, Fu D, Lau HY, Moochhala SM, Moore PK. Role of hydrogen sulfide in acute pancreatitis and associated lung injury. FASEB J. 2005 19 : 623 5.
17. Mnke M, Kraus JP, Ohura T, Franke U. The gene for cystathionine beta-synthase (CBS) maps to the subtelomeric region on human chromosome 21q and to proximal mouse chromosome 17. Am J Hum Gene. 1988 42 : 550 9.
18. Ge Y, Jensen TL, Matherly LH, Taub JW. Transcriptional regulation of the human cystathionine beta-synthase-1b basal promoter: synergistic transactivation by transcription factors NF-Y and Sp1/Sp3. Biochem J. 2001 357 : 97 105.
19. Maclean KN, Janosik M, Kraus E, Kozich V, Allen RH, Raab BK, Kraus JP. Cystathionine beta-synthase is coordi-nately regulated with proliferation through a redox-sensitive mechanism in cultured human cells and Saccharomyces cere-visiae. J Cell Physiol. 2002 192 : 81 92.
20. Prudova A, Bauman Z, Braun A, Vitvistky V, Lu SC, Banergee R. S-adenosylmethionine stabilizes cystathionine beta-synthase and modulates redox capacity. Proc Natl Acad Sci USA. 2006 103 : 6489 94.
21. Kimura Y, Dargush R, Schubert D, Kimura H. Hydrogen sulfide protects HT22 neuronal cells from oxidative stress. Antioxid Redox Signal. 2006 8 : 661 70.
22. Kimura Y, Kimura H. Hydrogen sulphide protects neurons from oxidative stress. FASEB J. 2004 18 : 1165 7.
23. Whiteman M, Cheung NS, Zhu Y-Z, Chu SH, Siau J-L, Wong BS, Armstrong JS, Moore PK. Hydrogen sulphide; a novel inhibitor of hypochlorous acid mediated oxidative damage in the brain? Biochem Biophys Res Commun. 2005 326 : 794 8.
24. Chang L, Geng B, Yu F, Zhao J, Jiang H, Du J, Tang C. Hydrogen sulfide inhibits myocardial injury induced by homocysteine in rats. Amino Acids. 2008 34 : 573 85.
25. Geng B, Chang L, Pan C, Qi, Y, Zhao J, Pang Y, Du J, Tang C. Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol. Biochem Biophys Res Commun. 2004 318 : 756 63.
26. Whiteman M, Li L, Kostetski I, Chu SH, Siau J-L, Bhatia M, Moore PK. Evidence for the formation of a novel nitrosothiol from the gaseous mediators nitric oxide and hydrogen sulfide. Biochem Biophys Res Commun. 2006 343 : 303 10.
27. Ishii I, Akahoshi N, Yu XN, Kobayahsi Y, Namekata K, Komaki G, Kimura H. Murine cystathionine gamma-lyase: complete cDNA and genomic sequences, promoter activity, tissue distribution and developmental expression. Biochem J. 2004 381 : 13 23.
28. 2S, a neuromodulator and smooth muscle relaxant. Nutr Rev. 2004 62 : 348 53.
29. Cheung NS, Peng ZF, Chen JM, Moore PK, Whiteman M. Hydrogen sulfide induced neuronal cell death occurs via glu-tamate receptor activation and is associated with calpain activation and lysosomal rupture in mouse primary cortical neurons. Neuropharmacol. 2007 53 : 505 14.
30. Kimura H. Hydrogen sulfide as a neuro-modulator. Mol Neurobiol. 2002 26 : 13 9.
31. Lawrence NS, Davis J, Compton RG. Analytical strategies for the detection of sulfide: a review. Talanta. 2000 52 : 771 84.
32. Li L, Moore PK. Putative biological roles of hydrogen sulfide in health and disease: a breath of not so fresh air? Trends Pharmacol Sci. 2008 29 : 84 90.
33. Chen Y-H, Yao W-Z, Geng B, Ding Y-L, Lu M, Zhao M-W, Tang C-S. Endogenous hydrogen sulfide in patients with COPD. Chest. 2005 128 : 3205 11.
34. Chang L, Geng B, Yu F, Zhao J, Jian H, Du J, Tang C. Hydrogen sulfide inhibits myocardial injury induced by homocys-teine in rats. Amino Acids. 2008 34 : 573 85.
35. Hyspler R, Ticha A, Indrova M, Zakak ZK, Hysplerova L, Gasparic J, Churacek J. A simple, optimized method for the determination of sulphide in whole blood by GC-MS as a marker of bowel fermentation processes. J Chromatog B: Anal Tech Biomed Life Sci. 2002 770 : 255 9.
36. Richardson CJ, Magee EAM, Cummings JH. A new method for the determination of sulphide in gastrointestinal contents and whole blood by microdistillation and ion chromatography. Clin Chem Acta. 2000 293 : 115 25.
37. Chunyu Z, Junabao, D, Dingfang B, Hui Y, Ziuying T, Chaoshu T. The regulatory effect of hydrogen sulfide on hypoxic pulmonary hypertension in rats. Biochem Biophys Res Commun. 2003 302 : 810 6.
38. 2S/sulfide concentration in vertebrate blood and its potential significance in ischemic preconditioning and vascular signaling. Am J Physiol Regul Integr Comp Physiol. 2008 294 : R1930 7.
39. Furne J, Saeed A, Levitt MD. Whole Tissue Hydrogen Sulfide Concentrations are Orders of Magnitude Lower than Presently Accepted Values. Am J Physiol Regul Integr Comp Physiol. 2008 295 : R1479 85.
40. Goubern M, Andriamihaja M, Nubel T, Blachier F, Bouillaud F. Sulfide, the first inorganic substrate for human cells. FASEB J. 2007 21 : 1699 706.
41. Hildebrandt TM, Grieshaber MK. Three enzymatic activities catalyze the oxidation of sulfide to thiosulfate in mammalian and invertebrate mitochondria. FEBS J. 2008 275 : 3352 61.
42. Millard J, Parsons RB, Waring RH, Williams AC, Ramsden DB. Expression of cysteine dioxygenase (E.C. 1.13.11.20) and sulfite oxidase in the human lung: a potential role for sulfate production in the protection from airborne xenobiotica. Mol Pathol. 2003 56 : 270 4.
43. Kage S, Nagata T, Takekawa K, Kimura K, Kudo K, Imamura T. The usefulness of thiosulfate as an indicator of hydrogen sulfide poisoning in forensic toxicological examination: A study with animal experiments. Jpn. J. Forensic Toxicol. 1992 10 : 223 7.
44. Milby TH, Baselt RC. Hydrogen sulfide poisoning: Clarification of some controversial issues. Am J Ind Med. 1999 35 : 192 5.
45. Berlardinelli MC, Chabli A, Chadefaux-Vekemans B, Kamoun P. Urinary sulfur compounds in Down syndrome. Clin Chem. 2001 47 : 1500 1.
46. Kage S, Ikeda H, Ikeda N, Tsujita A, Kudo K. Fatal hydrogen sulfide poisoning at a dye works. Legal Med. 2004 6 : 182 6.
47. Durand M, Weinstein P. Thiosulfate in human urine following minor exposure to hydrogen sulfide: implications for forensic analysis of poisoning. Forensic Toxicol. 2007 25 : 92 5.
48. Dorman DC, Moulin FJ, McManus BE, Mahle KC, James RA, Struve MF. Cytochrome oxidase inhibition induced by acute hydrogen sulfide inhalation: correlation with tissue sulfide concentrations in the rat brain, liver, lung, and nasal epithelium. Toxicol Sci. 2002 65 18 25.
49. Furne J, Springfield J, Koenig T, DeMaster E, Levitt MD. Oxidation of hydrogen sulfide and methanethiol to thiosulfate by rat tissues: a specialized function of the colonic mucosa. Biochem Pharmacol. 2001 62 : 255 9.
50. Levitt MD, Furne J, Springfield J, Suarez F, DeMaster E. Detoxification of hydrogen sulfide and methanethiol in the cecal mucosa. J Clin Invest. 1999 104 1107 14.
51. Ramasamy S, Singh S, Taniere P, Langman MJ, Eggo MC. Sulfide-detoxifying enzymes in the human colon are decreased in cancer and upregulated in differentiation. Am J Physiol Gastrointest Liver Physiol. 2006 291 : G288 96.
52. Mitsuhashi H, Yamashita S, Ikeuchi H, Kuroiwa T, Kaneko Y, Hiromura K, Ueki K, Nojima Y. Oxidative stress-dependent conversion of hydrogen sulfide to sulfite by activated neutrophils. Shock. 2005 24 : 529 34.
53. Johnston M, Jankowski D, Marcotte P, Tanaka H, Esaki N, Soda K, Walsh C. Suicide inactivation of bacterial cystathionine gamma-synthase and methionine gamma-lyase during processing of L-propargylglycine. Biochemistry. 1979 18 : 4690 701.
54. Konno R, Ikeda M, Yamaguchi K, Ueda Y, Niwa A. Nephrotoxicity of D-propargyl-glycine in mice. Arch Toxicol. 2000 74 473 9.
55. 2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science. 2008 322 : 587 90.
56. Chen C-Q, Xin H, Zhu Y-Z. Hydrogen sulfide: third gaseous transmitter, but with great pharmacological potential. Acta Pharmacol Sin. 2007 28 : 1709 16.
57. Webb GD, Lim LH, Oh VMS, Yeo SB, Cheong YP, Ali MY, Oakley RE, Lee CN, Wong PS, Caleb MG, Salto-Tellez M, Bhatia M, Chan ESY, Taylor EA, Moore PK. Contractile and vasorelaxant effects of hydrogen sulfide and its biosynthesis in the human internal mammary aterty. J Pharmacol Exp Therap. 2008 324 : 876 82.
58. Levonen AL, Lapatto R, Saksela M, Raivio KO. Human cystathionine-γ- lyase: developmental and in vitro expression of two isoforms. Biochem J. 2000 347 : 291 5.
59. Glode LM, Epstein M, Smith GA. Reduced cystathionine-γ-lyase protein content in human malignant leukemia cell lines as measured by immunoassay with monoclonal antibody. Cancer Res. 1981 41 : 2249 54.
60. 2S in patients with coronary heart disease. Di Yi Jun Yi Da Xue Xue Bao. 2005 25 : 951 4.
61. Yan H, Du J, Tang C. The possible role of hydrogen sulfide on the pathogenesis of spontaneous hypertension in rats. Biochem Biophys Res Commun. 2004 313 : 22 7.
62. Mok Y-YP, Atan MSBM, Ping CY, Ping WZ, Bhatia M, Moochala S, Moore KP Role of hydrogen sulphide in hemorrhagic shock in the rat: protective effect of inhibitors of hydrogen sulphide biosynthesis. Br J Pharmacol. 2004 143 : 881 9.
63. 2S in rat tissues. Can J Physiol Pharmacol. 2003 81 : 848 53.
64. Hosoki R, Matsuki N, Kimura H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun. 1997 237 : 527 31.
65. Ali MY Cheong YP Mok Y-YP, Whiteman M, Bhatia M, Moore PK. Effect of hydrogen sulfide and nitric oxide alone and together on rat aortic contractility and blood pressure. Br J Pharmacol. 2006 149 : 625 34.
66. Srilatha B, Adaikan PG, Li L, Moore PK. Hydrogen sulphide: a novel endogenous gasotransmitter facilitates erectile function. J Sex Med. 2007 4 : 1304 11.
67. Cheng Y, Ndisan JF, Tang G, Cao K, Wang R. Hydrogen sulfide-induced relaxation of resistance mesenteric artery beds of rats. Am J Physiol Heart Circ Physiol. 2004 287 : H2316 23.
68. 2S regulates perfusion pressure in both the isolated and perfused normal rat liver and in cirrhosis. Hepatol. 2005 : 42 539 48.
69. Pan TT, Feng ZN, Lee SW, Moore PK, Bian JS. Endogenous hydrogen sulfide contributes to the cardioprotection by metabolic inhibition preconditioning in the rat ventricular myocytes. J Mol Cell Cardiol. 2006 40 : 119 30.
70. Zhu YZ, Wang ZJ, Ho P, Loke YY, Zhu YC, Huang XW, Huang SH, Tan CS, Whiteman M, Lu J, Moore PK. Hydrogen sulfide and its cardioprotective effects in myocardial ischemia in experimental rats. J Appl Physiol. 2007 102 261 8.
71. AT P channels. Basic Res Cardiol. 2006 101 : 53 60.
72. Elrod JW, Calvert JW, Morrison J, Doeller JE, Kraus DW, Tao L, Jiao X, Kiss L, Szabo C, Kimura H, Chow CW, Lefer DJ. Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci USA. 2007 104 : 15560 5.
73. AT P channel opener. EMBO J. 2001 20 : 6008 16.
74. Tang G, Wu L, Liang W, Wang R. Direct stimulation of K(ATP) channels by exogenous and endogenous hydrogen sulfide in vascular smooth muscle cells. Mol Pharmacol. 2005 68 : 1757 64.
75. 2S induced vasorelaxation and underlying cellular and molecular mechanisms. Am J Physiol Heart Circ Physiol. 2002 283 : H474 80.
76. Sun YG, Cao YX, Wang WW, Ma SF, Yao T, Zhu YC. Hydrogen sulfide is an inhibitor of L-type calcium channels and mechanical contraction in rat cardiomyocytes. Cardiovasc Res. 2008 79 : 632 41.
77. 1 activity in human vascular smooth muscle cells. J Vasc Res. 2008 45 : 521 8.
78. Cai WJ, Wang MJ, Moore PK, Jin HM, Yao T, Zhu YC. The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation. Cardiovasc Res. 2007 76 : 29 40.
79. Li L, Whiteman M, Tan CH, Guan YY, Neo KL, Cheng Y, Lee SH, Zhao Y, Baskar R, Moore PK. Characterisation of a novel, water soluble hydrogen sulfide releasing molecule (GYY4137): new insights into the biology of hydrogen sulphide. Circulation. 2008 117 : 2351 60.
80. Zhong G, Chen F, Cheng Y, Tang C, Du J. The role of hydrogen sulfide generation in the pathogenesis of hypertension in rats induced by inhibition of nitric oxide syn-thase. J Hypertension. 2003 21 : 1879 85.
81. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B. Hyperhomo-cysteinemia: an independent risk factor for vascular disease. N Engl J Med. 1991 324 : 1149 55.
82. Eberhardt RT, Forgione MA, Cap A, Leopold JA, Rudd MA, Trolliet M. Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia. J Clin Invest. 2000 106 : 483 91.
83. Wierzbicki AS. Homocysteine and cardiovascular disease: a review of the evidence. Diab Vasc Dis Res. 2007 4 : 143 50.
84. Faeh D, Chiolero A, Paccaud F. Homocysteine as a risk factor for cardiovascular disease: should we (still) worry about? Swiss Med Wkly. 2006 136 : 745 56.
85. McKinely MC. Nutritional aspects and possible pathological mechanisms of hyper-homocysteinaemia: an independent risk factor for vascular disease. Proc Nutr Soc. 2000 59 : 221 37.
86. Moat SJ, Lang D, McDowell IF, Clarke ZL, Madhavan AK, Lewis MJ, Goodfellow J. Folate, homocysteine, endothelial function and cardiovascular disease. J Nutr Biochem. 2004 15 : 64 79.
87. Suhara T, Fukuo K, Yasuda O, Tsubakimoto M, Takemura Y, Kawamoto H, Yokai T, Mogi M, Kaimoto T, Ogihara T. Homocysteine enhances endothelial apoptosis via upregulation of Fas-mediated pathways. Hypertension. 2004 43 : 1208 13.
88. Xu D, Neville R, Finkel T. Homocysteine accelerates endothelial cell senescence. FEBS Lett. 2000 470 : 20 4.
89. Koga T, Claycombe K, Meydani M. Homocysteine increases monocyte and T-cell adhesion to human aortic endothelial cells. Atherosclerosis. 2002 161 : 365 74.
90. Dalal S, Parkin SM, Homer-Vanniasinkam S, Nicolaou A. Effect of homocysteine on cytokine production by human endothelial cells and monocytes. Ann Clin Biochem. 2003 40 : 534 41.
91. Fu WY, Dudman NP, Perry NP, Wang XL. Homocysteine attenuates hemodynamic responses to nitric oxide in vivo. Atherosclerosis. 2002 161 : 169 76.
92. Stamler JS, Osborne JA, Jaraki O, Rabbani LE, Mullins M, Singel D, Loscalzo J. (1993) Adverse effects of homocysteine are modulated by endothelium-derived relaxing factor and oxides of nitrogen. J Clin Invest. 2003 91 : 308 18.
93. Upchurch GR, Welch GN, Fabian AJ, Freedman JE, Johnson JL, Keaney JF, Loscalzo J. Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem. 1997 272 : 17012 7.
94. Upchurch GR, Welch GN, Loscalzo J. Homocysteine, EDRF and endothelial function. J Nutrition. 1996 126 : 1290S 4S.
95. Chen L, Sumou I, Ding Y-G, Liu Y, Qi J-G, Tang C-S, Du J-B. Imbalance of endogenous homocysteine and hydrogen sulfide metabolic pathway in essential hypertensive children. Chin Med J. 2007 120 : 389 93.
96. Zagli G, Patacchini R, Trevisani M, Abbate R, Cinotti S, Gensini G, Masotti G, Geppetti P. Hydrogen sulfide inhibits human platelet aggregation. Eur J Pharmacol. 2007 559 : 65 8.
97. Laggner H, Meullner MK, Schreier S, Sturm B, Hermann M, Exner M, Gmeiner M, Gmeiner BM, Kapiotis S. Hydrogen sulphide: a novel physiological inhibitor of LDL atherogenic modification by HOCl. Free Radic Res. 2007 41 : 741 7.
98. Hu Y, Chen X, Pan TT, Neo KL, Lee SW, Khin ES, Moore PK, Bian JS. Cardioprotection induced by hydrogen sul-fide preconditioning involves activation of ERK and PI3K/Akt pathways. Pflugers Arch. 2008 455 : 607 16.
99. Sivarajah A, Collino M, Yasin M, Benetti E, Gallicchio M, Mazzon E, Cuzzocrea S, Fantozzi R, Thiemermann C. Antiapoptotic and anti-inflammatory effects of hydrogen sulfide in a rat model of regional myocardial I/R. Shock. 2009 31 : 267 74.
100. Meng QH, Yang G, Yang W, Jiang B, Wu L, Wang R. Protective effect of hydrogen sulfide on balloon injury-induced neointima hyperplasia in rat carotid arteries. Am J Pathol. 2007 170 : 1406 14.
101. Du J, Hui J, Cheung Y, Bin H, Jiang X, Chen C, Tang C. The possible role of hydrogen sulfide as a smooth muscle cell proliferation inhibitor in rat cultured cells. Heart Vessels. 2004 19 : 75 80.
102. 2S-dependent modulation of ERK1/2 phosphorylation and p21Cip/WAK-1. J Biol Chem. 2004 279 : 49199 205.
103. 2S on human aorta smooth muscle cells. FASEB J. 2006 20 : 553 5.
104. Yang G, Sun X, Wang R. Hydrogen sulfide-induced apoptosis of human aorta smooth muscle cells via the activation of mitogen-activated protein kinases and caspase-3. FASEB J. 2004 18 : 1782 4.
105. Laggner H, Hermann M, Esterbauer H, Muellner MK, Exner M, Gmeiner BM, Kapiotis S. The novel gaseous vasorelaxant hydrogen sulfide inhibits angiotensin-converting enzyme activity of endothelial cells. J Hypertens. 2007 25 : 2100 4.
106. Olson KR, Dombkowksi RA, Russell MJ, Doellman MM, Head SK, Whitfield NL, Madden JA. Hydrogen sulfide as an oxygen sensor/transducer in vertebrate hypoxic vasoconstriction and hypoxic vasodilation. J Exp Biol. 2006 209 : 4011 23.
107. Kubo S, Doe I, Kurokawa Y, Nishikawa H, Kawabata A. Direct inhibition of endothelial nitric oxide synthase by hydrogen sulfide: contribution to dual modulation of vascular tension. Toxicol. 2007 232 : 138 46.
108. Kubo S, Kurokawa Y, Doe I, Masuko T, Sekiguchi F, Kawabata A. Hydrogen sulfide inhibits activity of three isoforms or recombinant nitric oxide synthase. Toxicol. 2007 241 : 92 7.
109. Geng B, Cui Y, Zhao J, Yu F, Zhu Y, Xu G, Zhang Z, Tang C, Du J. Hydrogen sulfide downregulates the aortic L-arginine/nitric oxide pathway in rats. Am J Physiol Regul Integr Comp Physiol. 2007 293 : R1608 18.
110. Yanfei W, Lin S, Du J, Tang C. Impact of L-arginine on hydrogen sulfide/cystathionine-y-lyase pathway in rats with high blood flow-induced pulmonary hypertension. Biochem Biophys Res Commun. 2006 345 : 851 7.
111. Xiaohui L, Junbao D, Lin S, Jian L, Xiuying T, Jianguang Q, Bing Q, Hongfang H, Chaoshu T. Down-regulation of endogenous hydrogen sulfide pathway in pulmonary hypertension and pulmonary vascular structural remodeling induced by high pulmonary blood flow in rats. Circ J. 2005 69 : 1418 24.
112. Eto K, Kimura H. A novel enhancing mechanism for hydrogen sulfide-producing activity of cystathionine (β-synthase. J Biol Chem. 2002 277 : 2680 5.
113. Li L, Rossoni G, Sparatore A, Lee LC, Del Soldato P, Moore PK. Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative. Free Radic Biol Med. 2007 42 : 706 19.
114. Wei HL, Zhang CY, Jin HF, Tang CS, Du JB. Hydrogen sulfide regulates lung tissue-oxidized glutathione and total antioxidant capacity in hypoxic pulmonary hypertensive rats. Acta Pharmacol Sin. 2008 29 : 670 9.
115. 2S protects myocardium against ischemia/reperfusion injury and its effect on c-Fos protein expression in rats. Sheng Li Xue Bao. 2008 60 : 221 7.
116. Bhatia M, Sidhapuriwala JN, Ng SW, Tamizhselvi R, Moochhala SM. Pro-inflammatory effects of hydrogen sulphide on substance P in caerulein-induced acute pancreatitis. J Cell Mol Med. 2008 12 : 580 90.
117. Bhatia M, Wong FL, Fu D, Lau HY, Moochhala SM, Moore PK. Role of hydrogen sulfide in acute pancreatitis and associated lung injury. FASEB J. 2005 19 : 623 5.
118. Zhang H, Zhi L, Moore PK, Bhatia M. Role of hydrogen sulfide in cecal ligation and puncture-induced sepsis in the mouse. Am J Lung Cell Mol. Physiol. 2006 290 : L1193 201.
119. 2S is impaired in non-obese diabetic (NOD) mice. Brit J Pharmacol. 2008 155 : 673 80.
120. Chen Y-H, Yao W-Z, Ding Y-L, Geng B, Lu M, Tang C-S. Effect of theophylline on endogenous hydrogen slfide production in patients with COPD. Pulmon. Pharmacol Therapeut. 2008 21 : 40 6.
121. Yong QC, Lee SW, Foo CS, Neo KL, Chen X, Bian JS. Endogenous hydrogen sulphide mediates the cardioprotection induced by ischemic postconditioning. Am J Physiol Heart Circ Physiol. 2008 295 : H1330 40.
122. Jeong S-O. Pate H-O, Oh G-S, Jeong G-S, Lee B-S, Lee S, Kim DY, Rhew HY, Lee K-M, Chung H-T. Hydrogen sulfide potentiates interleukin-1 β-induced nitric oxide production via enhancement of extracellular signal-regulated kinase activation in rat vascular smooth muscle cells. Bioche. Biophys Res Commun. 2006 345 : 938 44.
123. Liew HC, Khoo HE, Moore OK, Bhatia M, Lu J, Moochhalla SM. Synergism between hydrogen sulfide (H(2)S) and nitric oxide (NO) in vasorelaxation induced by stonustoxin (SNTX), a lethal and hypotensive protein factor isolated from stonefish Synanceja horrida venom. Life Sci. 2007 80 : 1664 8.
124. Wang YF, Mainali P, Tang CS, Shi L, Zhang CY, Yan H, Lui ZQ, Du JB. Effects of nitric oxide and hydrogen sulfide on the relaxation of pulmonary arteries in rats. Chin Med J. 2008 121 : 420 3.